Biofrontera AG Long Term Debt

Biofrontera AG (BFRA) currently reports a long-term debt of $2M as of September 2021. That compares with $30M in the prior-year period — down 93.4% year over year. Use the charts on this page to explore Biofrontera AG's long-term debt history and peer comparisons.

Biofrontera AG's long-term debt decreased from $30M to $2M — a 93.4% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera AG reported $2M in long-term debt as of September 2021. That compares with $30M in the prior-year period — down 93.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biofrontera AG, and consider following BFRA for alerts when major investors trade the stock.

Biofrontera AG is classified in the Healthcare sector. On long-term debt, it currently shows $2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BFRA with unrelated industries.